Synthesis and antimicrobial activity of novel globomycin analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 14, 2003, Pages 2315-2318

  Kiho, Toshihiro ^a   Nakayama, Mizuka ^a   Yasuda, Kayo ^a   Miyakoshi, Shunichi ^a   Inukai, Masatoshi ^a   Kogen, Hiroshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; NONHUMAN; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0038680576     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00432-3     Document Type: Article

References (29)

1. (a). Taxonomy of producing organism and fermentation: Inukai M., Enokita R., Torikata A., Nakahara M., Iwado S., Arai M. J. Antibiot. 31:1978;410
2. (b). Isolation and physico-chemical and biological characterization: Inukai M., Nakajima M., Osawa M., Haneishi T., Arai M. J. Antibiot. 31:1978;421
3. (c). Structural determination of 1a: Nakajima M., Inukai M., Haneishi T., Terahara A., Arai M. J. Antibiot. 31:1978;426
4. (d) Kogen H., Kiho T., Nakayama M., Furukawa Y., Kinoshita T., Inukai M. J. Am. Chem. Soc. 122:2000;10214
5. (e) Kiho T., Nakayama M., Kogen H. Tetrahedron. 59:2003;1685.
6. (a) Omoto S., Suzuki H., Inouye S. J. Antibiot. 32:1979;83
7. (b) Omoto S., Ogino H., Inouye S. J. Antibiot. 34:1981;1416.
8. Pugsley A.P. Microbiol. Rev. 57:1993;50.
9. (a) Inukai M., Takeuchi M., Shimizu K., Arai M. J. Antibiot. 31:1978;1203
10. (b) Hussain M., Ichihara S., Mizushima S. J. Biol. Chem. 255:1980;3707
11. (c) Dev I.K., Harvey R.J., Ray P.H. J. Biol. Chem. 260:1985;5891
12. (d) Ichihara S., Hussain M., Mizushima S. J. Biol. Chem. 256:1981;3125
13. (e) Witke C., Götz F. FEMS Microl. Lett. 126:1995;233
14. (f) Braun, B.; Wu, H. C. In Bacterial Cell Wall; Ghuysen, J. M., Hakenbeck, R., Eds.; Elsevier: Amsterdam, 1994; Chapter 14.
15. Cavard D. Arch. Microbiol. 171:1998;50.
16. Synthesis of three fragments, Fragment A, B and C, were performed by the method described in refs 1d and 1e.
17. Abiko A., Liu J.-F., Masamune S. J. Am. Chem. Soc. 119:1997;2586.
18. 12 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate.
19. Coste J., Le-Nguyen D., Castro B. Tetrahedron Lett. 31:1990;205.
20. Shioiri T., Yokoyama Y., Kasai Y., Yamada S. Tetrahedron. 32:1976;2211.
21. Boden E.P., Keck G.E. J. Org. Chem. 50:1985;2394.
22. (a) Carpino L.A., El-Faham A. J. Org. Chem. 59:1994;695
23. (b) Carpino L.A. J. Am. Chem. Soc. 115:1993;4397
24. (c) Carpino L.A., El-Faham A. J. Org. Chem. 60:1995;3561
25. (d) Humphrey J.M., Chamberlin A. R. Chem. Rev. 97:1997;2243.
26. 1H NMR suggested that other analogues (1a-1h) exist as a mixture of rotational isomers in solution.
27. 3OH).
28. 2b O-Bn or O-Me globomycin derivatives in L-Ser residue were inactive against E. coli SANK 70569 tested only (MIC>50 μg/mL).
29. National Committee for Clinical Laboratory Standards. Standard Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard (M7-A5); NCCLS: Villanova, 2000; p 7.